Out-of-pocket trends in Medicare Part D show rising costs for seniors

Anew study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and multiple sclerosis. The analysis, which looked at spending trends among non-low-income subsidy (non-LIS) Part D beneficiaries from 2015 to 2019 across all brand medicines and several therapeutic areas, reaffirms the need for targeted solutions to strengthen the program. Here are three findings you should know. 
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Part D Out-of-Pocket Costs Source Type: news